Caldwell William S

CIK 00012958291 companyWINSTON-SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001295829

Recent Transactions

50 trades

Gift
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-09-20−500→ 7,235 total
Gift
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-09-20−500→ 6,735 total
Gift
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-09-20+500→ 500 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-03-31$2.93/sh+2,655→ 10,390 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-03-31$26.37/sh−2,655→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-03-31−2,655→ 18,595 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-03-29+40,000→ 40,000 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-03-01$30.00/sh−11,360→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-03-01−11,360→ 31,472 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-03-01$8.51/sh+11,360→ 19,095 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-02-28−15,481→ 0 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-02-28$28.00/sh−15,481→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-02-28$5.55/sh+15,481→ 23,216 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-02-16$26.52/sh−16,655→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-02-16$1.75/sh+16,655→ 24,390 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-02-16−16,655→ 21,250 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-13−12,000→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-13$1.75/sh+12,000→ 19,735 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-13$23.95/sh−12,000→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-05-03−14,278→ 42,832 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$8.51/sh+14,278→ 24,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-05-03−2,722→ 21,547 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$24.29/sh−17,000→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$5.55/sh+2,722→ 10,457 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-30$5.55/sh+15,263→ 22,998 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-30$24.27/sh−15,263→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-30−15,263→ 24,269 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-29$5.55/sh+22,015→ 42,835 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-29$24.18/sh−35,100→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-29$1.75/sh+13,085→ 20,820 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-29−22,015→ 39,532 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-29−22,015→ 33,466 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-29−13,085→ 12,000 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-28$1.75/sh+16,000→ 23,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-28−16,000→ 25,085 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-28$24.00/sh−16,000→ 7,735 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-27$24.00/sh−315→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-27$1.75/sh+315→ 8,050 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-27−315→ 41,085 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-26−600→ 41,400 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-26$24.00/sh−600→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-26$1.75/sh+600→ 8,335 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-20$23.00/sh−15,900→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-20$5.55/sh+8,655→ 23,635 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-20$5.10/sh+7,245→ 14,980 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-20−7,245→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-20−6,066→ 55,481 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-20−2,589→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-19$5.10/sh+100→ 7,835 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-19−100→ 7,245 total

Companies

GYRE THERAPEUTICS, INC.
VP - Drug Discovery and Dev.
$GYRE

Recent Filings

Address

C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101

View on SEC.gov